Health ProductsType I recall

ACH-SITAGLIPTIN: May exceed established acceptable intake limit for NTTP.

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: ACH-SITAGLIPTIN
Issue: Health products - Product safety
What to do: Consult your health care professional if you have any health concerns.
Audience: General public, Healthcare, Industry
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

BrandLotProduct NameMarket AuthorizationDosage FormStrength
ACH-SITAGLIPTINP2206575, P2206981ACH-SITAGLIPTINDIN 02512491TabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 100 MG
ACH-SITAGLIPTINP2206573ACH-SITAGLIPTINDIN 02512475TabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 25 MG
ACH-SITAGLIPTINP2206574ACH-SITAGLIPTINDIN 02512483TabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MG

Issue

The affected lots may exceed the established acceptable intake limit for 7-nitroso-3-(trifluoromethyl)- 5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine (NTTP).

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime